Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN). - Test2 - elhamkhani - TriplyDB

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

http://www.wikidata.org/entity/Q46719997

about

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Mitochondrial Dynamics Decrease Prior to Axon Degeneration Induced by Vincristine and are Partially Rescued by Overexpressed cytNmnat1 Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.Toxicities of Therapeutic Agents Used in Medicine.Oxaliplatin-induced Peripheral Neuropathy in South Indian Cancer Patients: A Prospective Study in Digestive Tract Cancer Patients.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon.Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy.Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.

P2860

Q33744706-63A2E5DB-EEC5-4CEC-BD01-1D7A8FAE6E15 Q37104479-B50E1ABB-997A-4531-ADAB-109FED3DCE2A Q38719679-6A523584-44D5-4DBD-825F-07533072CE10 Q41367937-83AF53FE-8A03-4593-91DB-AD25E7331FFD Q42361402-C6847876-6C79-4641-8B5E-A7BE3C9EED9C Q49439093-253DB59A-F65E-4E81-9197-0A8B8D4205F6 Q54959206-3E66439F-909B-4964-AA54-13C1CA33828B Q55198257-07591FE3-CE77-41A2-B17F-22EAFA3B9210 Q55340197-6297C571-8B3E-40C9-A310-DD5B7886F166 Q55364011-60316EAE-CCD9-46C8-838A-07EAFC254C7B

P2860

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

http://www.wikidata.org/entity/Q46719997

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

@en

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy

@nl

type

label

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

@en

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy

@nl

prefLabel

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

@en

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy

@nl

P1433

Q46719997-C8C25BE6-212F-4B47-8232-63E27B1360DF

P1476

Q46719997-DEC0EC29-22B8-4E83-91EC-D195670FF132

P2093

Q46719997-51518729-7F56-44CB-A7AC-494BCF154691

Q46719997-EE0E7B2A-D286-4734-A3EF-DD7A169EDA0E

P2860

Q46719997-00219BD1-0C31-471C-A6DB-5820A9066926

Q46719997-01CCF6E9-3E43-448C-8542-A06B84B19387

Q46719997-0220B411-DB90-47AF-8226-E7818B835D20

Q46719997-03763CE2-2A28-442B-934F-59461D72CDF4

Q46719997-03BF9552-84EF-4898-B01A-0EBFFD98742B

Q46719997-043A5B3A-4E2A-4389-A03D-390EC48A6FDC

Q46719997-04E9B166-553A-4726-98A3-8E473049FDFF

Q46719997-064DC9A1-33A6-4D40-A364-542FDF79C998

Q46719997-07402324-C8D5-4FE8-BD17-10C2D15F6A7B

Q46719997-086B29BE-B3A1-4404-B1CC-E311972E02EC

P304

Q46719997-819A956B-481B-462C-9D7F-CF856EC658A9

P31

Q46719997-BD0AF721-26D1-4852-8360-5ACEAF8FB12C

P356

Q46719997-A87A8F18-EFB9-446E-BC42-894E9E0D2E02

P433

Q46719997-02A45A93-3F98-4026-A0B2-EC400A5AD438

P478

Q46719997-0C87DE8B-1795-480D-ADB8-3178795F5A0B

P50

Q46719997-4BF3C67A-E46F-454D-8D7F-19BCD0D24C5E

P577

Q46719997-14063856-1D48-4B2E-A3C1-5FF52B58135E

P698

Q46719997-F13958C9-6DD9-49C0-B154-60D3A9B04055

P921

Q46719997-5E36B1E4-2767-4788-98D7-7CCFA3321C64

P932

Q46719997-D386E36D-1A4A-44F2-A3C2-ED58BC4607F2

P356

P1433

P1476

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

@en

P2093

Annalisa Canta

http://www.w3.org/2001/XMLSchema#string

Eleonora Pozzi

http://www.w3.org/2001/XMLSchema#string

P2860

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

Microtubule-binding agents: a dynamic field of cancer therapeutics.

Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'

Microtubules as a target for anticancer drugs

Nucleolar damage correlates with neurotoxicity induced by different platinum drugs

Clinical and electrophysiological studies in vincristine induced neuropathy

Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions

Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy

Aerobic metabolism underlies complexity and capacity

Mitotoxicity in distal symmetrical sensory peripheral neuropathies

P304

198-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXICS3020198

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Valentina Alda Carozzi

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29056658

http://www.w3.org/2001/XMLSchema#string

P921

P932

5634687

http://www.w3.org/2001/XMLSchema#string